Beta-blocker therapy and risk of vascular dementia: A population-based prospective study.
There are a few studies that report cognitive impairment as a complication of treatment with beta- blockers. We aimed to evaluate the longitudinal association between use of beta-blockers, as a class, and incident risk of all-cause dementia, vascular dementia, Alzheimer's and mixed dementia in the prospective population-based Malmö Preventive Project. We included 18,063 individuals (mean age 68.2,
https://www.lupop.lu.se/article/beta-blocker-therapy-and-risk-vascular-dementia-population-based-prospective-study - 2025-12-29
